[Frontiers in Bioscience E5, 748-754, January 1, 2013]
Association of VEGF +405G>C polymorphism with endometriosis
Maria Celestina Vanaja1, Roya Rozati2, Khaja Nassaruddin3, Satti Vishnupriya5
1M.Sc. Research Scholar, MHRT Hospital and Research Centre, Owaisi Hospital and Research Centrre Hyderabad, 2M.D., A.I.I.M.S, Delhi, F.R.C.O.G., London, Chief Fertility Specialist, Research Director of MHRT-Hospital and Research Centre, Professor and Head Owaisi Hospital, Deccan College of Medical Sciences,3C.T.O. of Bioserve Biotechnologies India Pvt Ltd, Hyderabad, 500076, 4M.Sc, M.Phil. Scientist R and D, Bioserve Biotechnologies India Pvt Ltd, Hyderabad, 500076, 5Head, Department of Genetics, Osmania University, Hyderabad
TABLE OF CONTENTS
The present study was designed to explore the association between the SNP +405G>C of the VEGF gene with the risk of endometriosis, and endometriosis associated with adenomyosis and chocolate cysts. Following extraction of genomic DNA, genotyping of the +405 G>C polymorphisms of the VEGF gene was performed by PCR - RFLP analysis. The genotype (X2 =21.713, 2 df, P = < 0.0001) and allele (X2 =10.697, 1 df, P = 0.0011) frequencies of endometriosis patients were significantly different from those of the control women. The genotype and allele frequencies significantly differed in all the clinical subgroups of endometriosis patients. The significant differences in allele frequencies were the result of an increased proportion of homozygote GG genotype carriers. No significant difference was observed between the clinical subgroups with respect to the genotype and allele frequencies of the VEGF +405G>C polymorphism. These findings suggest that the VEGF +405 G>C polymorphism is associated with the risk of endometriosis, and endometriosis associated with adenomyosis and chocolate cysts.